• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性淋巴结比率优于淋巴结转移数和 TNM/AJCC N 分类在预测甲状腺髓样癌的癌症特异性生存中的作用。

Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancer.

机构信息

Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Department of General, Visceral and Transplantation Surgery, Section of Endocrine Surgery, University of Duisburg-Essen, Essen, Germany.

出版信息

Head Neck. 2022 Dec;44(12):2717-2726. doi: 10.1002/hed.27181. Epub 2022 Sep 6.

DOI:10.1002/hed.27181
PMID:36065717
Abstract

BACKGROUND

In medullary thyroid cancer (MTC), it is unclear which nodal classification system, metastatic lymph node ratio (MLNR), number of node metastases, or TNM/AJCC N classification, predicts cancer-specific survival best.

METHODS

Kaplan-Maier analysis of cancer-specific survival after operation at a tertiary center.

RESULTS

Included were 505 MTC patients. The spread of the survival curves was greatest after stratification by MLNR (in 0.20 increments), followed by number of node metastases (in 10-node and 20-node increments) and TNM/AJCC classification (N0, N1a, N1b). After collapsing overlapping survival curves, all adjacent curves (MLNRs ≤0.20 vs. 0.21-0.60 vs. >0.60; 0 vs. 1-20 vs. >20 node metastases; and TNM/AJCC N classification N0/N1a vs. N1b) significantly differed between each other.

CONCLUSIONS

In MTC, MLNR, reflecting intensity of lymphatic spread, predicts cancer-specific survival better than number of node metastases or TNM/AJCC N classification. The applicability of these findings to patients with limited neck dissection requires more research.

摘要

背景

在甲状腺髓样癌(MTC)中,尚不清楚哪种淋巴结分类系统、转移淋巴结比例(MLNR)、淋巴结转移数量或 TNM/AJCC N 分类能更好地预测癌症特异性生存。

方法

在三级中心进行手术治疗后,采用 Kaplan-Meier 分析癌症特异性生存。

结果

共纳入 505 例 MTC 患者。在按 MLNR(每 0.20 个增量)、淋巴结转移数量(每 10 个和 20 个增量)和 TNM/AJCC 分类(N0、N1a、N1b)分层后,生存曲线的扩散程度最大。在合并重叠生存曲线后,所有相邻曲线(MLNRs ≤0.20 比 0.21-0.60 比 >0.60;0 比 1-20 比 >20 个淋巴结转移;以及 TNM/AJCC N 分类 N0/N1a 比 N1b)之间存在显著差异。

结论

在 MTC 中,反映淋巴扩散强度的 MLNR 比淋巴结转移数量或 TNM/AJCC N 分类更能预测癌症特异性生存。这些发现对接受有限颈部清扫术的患者的适用性需要进一步研究。

相似文献

1
Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer-specific survival in medullary thyroid cancer.转移性淋巴结比率优于淋巴结转移数和 TNM/AJCC N 分类在预测甲状腺髓样癌的癌症特异性生存中的作用。
Head Neck. 2022 Dec;44(12):2717-2726. doi: 10.1002/hed.27181. Epub 2022 Sep 6.
2
Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.转移性淋巴结比率可进一步对甲状腺髓样癌患者的死亡风险进行分层:一项基于人群的分析。
Oncotarget. 2016 Oct 4;7(40):65937-65945. doi: 10.18632/oncotarget.11725.
3
Prognostic analysis of esophageal cancer in elderly patients: metastatic lymph node ratio versus 2010 AJCC classification by lymph nodes.老年食管癌患者的预后分析:转移淋巴结比率与2010年美国癌症联合委员会(AJCC)淋巴结分类的比较
World J Surg Oncol. 2013 Jul 18;11:162. doi: 10.1186/1477-7819-11-162.
4
Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System.包含转移淋巴结数量的甲状腺髓样癌分期系统:验证改良的美国癌症联合委员会肿瘤-淋巴结-转移分期系统。
Thyroid. 2022 May;32(5):536-543. doi: 10.1089/thy.2021.0571. Epub 2022 May 3.
5
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌区域淋巴结转移的结外扩展的预后意义
Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29.
6
Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.甲状腺髓样癌中淋巴结收获量和转移淋巴结比例的预后价值
Ann Surg Oncol. 2008 Sep;15(9):2493-9. doi: 10.1245/s10434-008-0022-z. Epub 2008 Jul 2.
7
Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.第八版肿瘤-淋巴结-转移分期系统中 N1b 亚分期对甲状腺乳头状癌的修正:一项多机构队列研究。
Oral Oncol. 2018 Nov;86:48-52. doi: 10.1016/j.oraloncology.2018.09.008. Epub 2018 Sep 13.
8
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.颈侧区淋巴结转移(N1b)是甲状腺乳头状癌预后的另一个危险因素。
J Endocrinol Invest. 2017 Dec;40(12):1355-1363. doi: 10.1007/s40618-017-0714-y. Epub 2017 Jun 23.
9
A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.一种将病理检查淋巴结有限和足够数量的晚期胃癌患者进行分类的均一化方法。
Cancer Commun (Lond). 2019 Jun 10;39(1):32. doi: 10.1186/s40880-019-0370-z.
10
Prognostic Performance of Alternative Lymph Node Classification Systems for Patients with Medullary Thyroid Cancer: A Single Center Cohort Study.替代淋巴结分类系统对甲状腺髓样癌患者预后的预测性能:一项单中心队列研究。
Ann Surg Oncol. 2022 Apr;29(4):2561-2569. doi: 10.1245/s10434-021-11134-3. Epub 2021 Dec 10.

引用本文的文献

1
Prognostic factors for progression free survival in patients with medullary thyroid cancer: a multicenter cohort study.甲状腺髓样癌患者无进展生存期的预后因素:一项多中心队列研究。
Updates Surg. 2025 May 20. doi: 10.1007/s13304-025-02193-2.
2
Surgical Treatment of Medullary Thyroid Cancer.甲状腺髓样癌的外科治疗
Recent Results Cancer Res. 2025;223:247-266. doi: 10.1007/978-3-031-80396-3_10.
3
The prognostic value of lymphatic metastatic size in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中淋巴转移灶大小的预后价值。
Eur Arch Otorhinolaryngol. 2024 Jan;281(1):387-395. doi: 10.1007/s00405-023-08199-z. Epub 2023 Sep 8.
4
The number of metastatic lymph nodes optimizes staging in patients aged 55 years or older with papillary thyroid cancer.对于 55 岁及以上的甲状腺乳头状癌患者,转移淋巴结的数量可优化分期。
Front Endocrinol (Lausanne). 2022 Dec 9;13:1026737. doi: 10.3389/fendo.2022.1026737. eCollection 2022.